This Week in Managed CareUpdate on COVID-19 Vaccine Process and Other Health News

Published: June 22, 2020, 1:45 p.m.

b"Every week, The American Journal of Managed Care\\xae\\xa0recaps the top managed care news of the week.\\n\\nThis week, the top managed care news included more details about the COVID-19 vaccine process; attempts to reinforce social distancing amid reopening; a recap of the American Diabetes Association 2020 Virtual Scientific Sessions.\\n\\nRead more about the stories in this podcast:\\nUS Releases More Details About COVID-19 Vaccine Process, Says Some Doses Will Be Free: https://www.ajmc.com/newsroom/us-releases-more-details-about-covid19-vaccine-process-says-some-doses-will-be-free\\nWith States Reopening, CDC Tries to Reinforce Social Distancing Guidance: https://www.ajmc.com/newsroom/with-states-reopening-cdc-tries-to-reinforce-social-distancing-guidance\\nAmerican Diabetes Association 2020 Virtual Scientific Sessions: https://www.ajmc.com/conferences/ada-2020\\nWhat We're Reading: Drug Price TV Ruling Upheld; WHO Ends Hydroxychloroquine Study; Caution Issued on Rally Attendance: https://www.ajmc.com/newsroom/what-were-reading-drug-prices-not-required-in-tv-ads-who-ends-study-of-hydroxychloroquine-caution-issued-on-rally-attendance-\\nFDA Approves Second Biomarker-Based Indication for Pembrolizumab: https://www.ajmc.com/newsroom/fda-approves-second-biomarkerbased-indication-for-pembrolizumab\\nEffectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants: https://www.ajmc.com/journals/issue/2013/2013-1-vol19-n3/effectiveness-and-cost-effectiveness-of-diabetes-prevention-among-adherent-participants"